Annual ROE
-224.08%
-156.66%-232.36%
December 31, 2023
Summary
- As of February 8, 2025, VRCA annual return on equity is -224.08%, with the most recent change of -156.66% (-232.36%) on December 31, 2023.
- During the last 3 years, VRCA annual ROE has fallen by -94.65% (-73.13%).
- VRCA annual ROE is now -412.05% below its all-time high of 71.81%, reached on December 31, 2016.
Performance
VRCA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-2619.46%
-2208.13%-536.83%
September 30, 2024
Summary
- As of February 8, 2025, VRCA quarterly return on equity is -2619.46%, with the most recent change of -2208.13% (-536.83%) on September 30, 2024.
- Over the past year, VRCA quarterly ROE has dropped by -2521.80% (-2582.22%).
- VRCA quarterly ROE is now -4236.21% below its all-time high of 63.33%, reached on December 31, 2017.
Performance
VRCA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VRCA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -232.4% | -2582.2% |
| 3 y3 years | -73.1% | -3305.0% |
| 5 y5 years | -870.5% | -3305.0% |
VRCA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -232.4% | at low | -4850.8% | at low |
| 5 y | 5-year | -416.4% | at low | -6778.8% | at low |
| alltime | all time | -412.1% | at low | -4236.2% | at low |
Verrica Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -2619.46%(+536.8%) |
| Jun 2024 | - | -411.33%(+87.3%) |
| Mar 2024 | - | -219.61%(+45.8%) |
| Dec 2023 | -224.08%(+232.4%) | -150.66%(+54.3%) |
| Sep 2023 | - | -97.66%(+84.6%) |
| Jun 2023 | - | -52.91%(-10.4%) |
| Mar 2023 | - | -59.06%(-23.2%) |
| Dec 2022 | -67.42%(-37.0%) | -76.93%(-12.4%) |
| Sep 2022 | - | -87.81%(-28.3%) |
| Jun 2022 | - | -122.51%(+22.4%) |
| Mar 2022 | - | -100.11%(+25.8%) |
| Dec 2021 | -106.97% | -79.58%(-3.0%) |
| Sep 2021 | - | -82.04%(+5.5%) |
| Jun 2021 | - | -77.74%(+4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -74.12%(-23.1%) |
| Dec 2020 | -129.43%(+198.3%) | -96.35%(+34.9%) |
| Sep 2020 | - | -71.40%(+30.9%) |
| Jun 2020 | - | -54.53%(+20.5%) |
| Mar 2020 | - | -45.24%(+18.8%) |
| Dec 2019 | -43.39%(+87.9%) | -38.08%(+8.5%) |
| Sep 2019 | - | -35.11%(+8.4%) |
| Jun 2019 | - | -32.39%(+14.0%) |
| Mar 2019 | - | -28.40%(+8.4%) |
| Dec 2018 | -23.09%(-136.5%) | -26.21%(-1.2%) |
| Sep 2018 | - | -26.54%(+8.6%) |
| Jun 2018 | - | -24.43%(-55.9%) |
| Mar 2018 | - | -55.40%(-187.5%) |
| Dec 2017 | 63.33%(-11.8%) | 63.33% |
| Dec 2016 | 71.81% | - |
FAQ
- What is Verrica Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual ROE year-on-year change?
- What is Verrica Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly ROE year-on-year change?
What is Verrica Pharmaceuticals annual return on equity?
The current annual ROE of VRCA is -224.08%
What is the all time high annual ROE for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual return on equity is 71.81%
What is Verrica Pharmaceuticals annual ROE year-on-year change?
Over the past year, VRCA annual return on equity has changed by -156.66% (-232.36%)
What is Verrica Pharmaceuticals quarterly return on equity?
The current quarterly ROE of VRCA is -2619.46%
What is the all time high quarterly ROE for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly return on equity is 63.33%
What is Verrica Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, VRCA quarterly return on equity has changed by -2521.80% (-2582.22%)